{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:42:25Z","timestamp":1792629745162,"version":"4.5.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Pneumonia is a serious and common infectious disease in children. If not treated in time, it may develop into severe pneumonia. Severe pneumonia in children is mainly characterized by hypoxia and acidosis, often accompanied by various complications such as sepsis and multiple organ dysfunction. Severe pneumonia has a rapid onset and progression, and a high mortality rate. Biomarkers assist clinicians in the early diagnosis and treatment of patients by quickly and accurately identifying their conditions and prognostic risks. In this study, common clinical and novel biomarkers of severe pneumonia in children were reviewed, and the application value of biomarkers related to the severity and prognosis of severe pneumonia in children was evaluated to provide help for early identification and precise intervention by clinicians.<\/jats:p>","DOI":"10.3389\/fped.2024.1417644","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:33:46Z","timestamp":1727742826000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Research progress of biomarkers in evaluating the severity and prognostic value of severe pneumonia in children"],"prefix":"10.3389","volume":"12","author":[{"given":"Weihua","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ci","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"Cd009576","DOI":"10.1002\/14651858.CD009576.pub3","article-title":"Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze","volume":"1","author":"Lassi","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2471\/blt.07.048769","article-title":"Epidemiology and etiology of childhood pneumonia","volume":"86","author":"Rudan","year":"2008","journal-title":"Bull World Health Organ"},{"key":"B3","volume-title":"Revised wHO Classification and Treatment of Pneumonia in Children at Health Facilities: Evidence Summaries","year":"2014"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.4049\/jimmunol.2001395","article-title":"Critical role of zinc transporter (ZIP8) in myeloid innate immune cell function and the host response against bacterial pneumonia","volume":"207","author":"Hall","year":"2021","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.7150\/ijms.67028","article-title":"Serum IL-27 predicts the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study","volume":"19","author":"Xu","year":"2022","journal-title":"Int J Med Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"695134","DOI":"10.3389\/fcimb.2021.695134","article-title":"Comprehensive description of pathogens and antibiotic treatment guidance in children with community-acquired pneumonia using combined mass spectrometry methods","volume":"11","author":"Sun","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13052-023-01431-w","article-title":"Clinical evaluation of metagenomic next-generation sequencing for the detection of pathogens in BALF in severe community acquired pneumonia","volume":"49","author":"Wei","year":"2023","journal-title":"Ital J Pediatr"},{"key":"B8","first-page":"138","article-title":"Mortality from acute respiratory infections in children under 5 years of age: global estimates","volume":"39","author":"Leowski","year":"1986","journal-title":"World Health Stat Q"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e101112","DOI":"10.1371\/journal.pone.0101112","article-title":"Child mortality estimation 2013: an overview of updates in estimation methods by the united nations inter-agency group for child mortality estimation","volume":"9","author":"Alkema","year":"2014","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/s0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhoea","volume":"381","author":"Walker","year":"2013","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. Children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"B12","first-page":"618","article-title":"Community-acquired pneumonia in children: rapid evidence review","volume":"104","author":"Smith","year":"2021","journal-title":"Am Fam Physician"},{"key":"B13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.21037\/atm.2020.02.182","article-title":"Diagnostic markers for community-acquired pneumonia","volume":"8","author":"Ito","year":"2020","journal-title":"Ann Transl Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/s2214-109x(17)30448-5","article-title":"Appropriateness of clinical severity classification of new WHO childhood pneumonia guidance: a multi-hospital, retrospective, cohort study","volume":"6","author":"Agweyu","year":"2018","journal-title":"Lancet Glob Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13012-019-0868-4","article-title":"Effect of enhancing audit and feedback on uptake of childhood pneumonia treatment policy in hospitals that are part of a clinical network: a cluster randomized trial","volume":"14","author":"Ayieko","year":"2019","journal-title":"Implement Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1189684","DOI":"10.3389\/fpubh.2023.1189684","article-title":"Adherence to WHO guidelines on severe pneumonia management in children and its impact on outcome: an observational study at jinka general hospital in Ethiopia","volume":"11","author":"La Vecchia","year":"2023","journal-title":"Front Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/ijms18020447","article-title":"Biomarkers in pediatric community-acquired pneumonia","volume":"18","author":"Principi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3390\/ijms20082004","article-title":"Biomarkers in pneumonia-beyond procalcitonin","volume":"20","author":"Karakioulaki","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/s0140-6736(21)00630-9","article-title":"Community-acquired pneumonia","volume":"398","author":"Aliberti","year":"2021","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1183\/09031936.00060112","article-title":"Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia","volume":"41","author":"Paats","year":"2013","journal-title":"Eur Respir J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1164\/rccm.201709-1908OC","article-title":"Initial inflammatory profile in community-acquired pneumonia depends on time since onset of symptoms","volume":"198","author":"M\u00e9ndez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/cells11030424","article-title":"The underestimated role of platelets in severe infection a narrative review","volume":"11","author":"Fogagnolo","year":"2022","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-n","article-title":"High serum procalcitonin concentrations in patients with sepsis and infection","volume":"341","author":"Assicot","year":"1993","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00431-017-2913-0","article-title":"A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR","volume":"176","author":"Alcoba","year":"2017","journal-title":"Eur J Pediatr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12890-020-01207-6","article-title":"Procalcitonin and C-reactive protein perform better than the neutrophil\/lymphocyte count ratio in evaluating hospital acquired pneumonia","volume":"20","author":"Zheng","year":"2020","journal-title":"BMC Pulm Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.21037\/atm-20-3425","article-title":"Infection biomarkers in assisting the judgement of blood stream infection and patient prognosis: a retrospective study incorporating principal components analysis","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann Transl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1189\/jlb.0808491","article-title":"Differential lymphopenia-induced homeostatic proliferation for CD4+and CD8+ T cells following septic injury","volume":"85","author":"Unsinger","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood.V87.10.4261.bloodjournal87104261","article-title":"Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators","volume":"87","author":"Ayala","year":"1996","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0250067","DOI":"10.1371\/journal.pone.0250067","article-title":"Prognostic value of serial neutrophil-to-lymphocyte ratio measurements in hospitalized community-acquired pneumonia","volume":"16","author":"Lee","year":"2021","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cmet.2021.01.002","article-title":"The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19","volume":"33","author":"Cai","year":"2021","journal-title":"Cell Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1111\/jgs.14894","article-title":"Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia","volume":"65","author":"Cataudella","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3389\/fimmu.2019.02204","article-title":"The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases","volume":"10","author":"Guo","year":"2019","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"659677","DOI":"10.3389\/fped.2021.659677","article-title":"Explore the predictive value of peripheral blood cell parameters in refractory Mycoplasma pneumoniae pneumonia in children over 6 years old","volume":"9","author":"Ling","year":"2021","journal-title":"Front Pediatr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jacc.2014.12.061","article-title":"Platelet activation and pneumonia: is soluble p-selectin the right marker?","volume":"65","author":"Gurbel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/10408363.2014.992064","article-title":"Red blood cell distribution width: a simple parameter with multiple clinical applications","volume":"52","author":"Salvagno","year":"2015","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12872-022-02975-1","article-title":"Relationship between red blood cell distribution width-to-albumin ratio and outcome of septic patients with atrial fibrillation: a retrospective cohort study","volume":"22","author":"Gu","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"R282","DOI":"10.1186\/cc13145","article-title":"An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock","volume":"17","author":"Kim","year":"2013","journal-title":"Crit Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2020.01.001","article-title":"Diagnostic and prognostic value of red blood cell distribution width in sepsis: a narrative review","volume":"77","author":"Hu","year":"2020","journal-title":"Clin Biochem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2466-12-6","article-title":"Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ","volume":"12","author":"Zobel","year":"2012","journal-title":"BMC Pulm Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: from its discovery to clinical applications","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/17512433.2017.1268051","article-title":"Tools for outcome prediction in patients with community acquired pneumonia","volume":"10","author":"Khan","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1097\/CCM.0b013e3182257445","article-title":"Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia","volume":"39","author":"Ram\u00edrez","year":"2011","journal-title":"Crit Care Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12890-016-0324-z","article-title":"The balance between the serum levels of IL-6 and IL-10 cytokines discriminates mild and severe acute pneumonia","volume":"16","author":"de Brito","year":"2016","journal-title":"BMC Pulm Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1021\/pr101154j","article-title":"Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer","volume":"10","author":"Sung","year":"2011","journal-title":"J Proteome Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11883-020-00888-y","article-title":"Structural basis for vital function and malfunction of serum amyloid A: an acute-phase protein that wears hydrophobicity on its sleeve","volume":"22","author":"Gursky","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1080\/07853890.2022.2064542","article-title":"Value of combined detection of serum amyloid A, C-reactive protein and procalcitonin in differential diagnosis of respiratory tract infection in children of China","volume":"54","author":"Yin","year":"2022","journal-title":"Ann Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","article-title":"A test in context: d-dimer","volume":"70","author":"Weitz","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1378\/chest.126.4.1087","article-title":"Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia","volume":"126","author":"Querol-Ribelles","year":"2004","journal-title":"Chest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0263215","DOI":"10.1371\/journal.pone.0263215","article-title":"Value of D-dimer in predicting various clinical outcomes following community-acquired pneumonia: a network meta-analysis","volume":"17","author":"Li","year":"2022","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"638529","DOI":"10.3389\/fmed.2021.638529","article-title":"Serum prealbumin concentrations, COVID-19 severity, and mortality: a systematic review and meta-analysis","volume":"8","author":"Zinellu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jiac.2019.05.029","article-title":"\u03922 microglobulin and lactate dehydrogenase are indices of different features of Mycoplasma pneumoniae-associated community-acquired lower respiratory tract infection for severity evaluation in children","volume":"25","author":"Kusubae","year":"2019","journal-title":"J Infect Chemother"},{"key":"B55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2217\/fon-2018-0376","article-title":"Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2019","journal-title":"Future Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1180187","DOI":"10.3389\/fcimb.2023.1180187","article-title":"Implications of LDH in patients with coronavirus disease 2019 pneumonia","volume":"13","author":"Mu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"566797","DOI":"10.3389\/fped.2021.566797","article-title":"Analysis of clinical characteristics and risk factors of severe adenovirus pneumonia in children","volume":"9","author":"Zhong","year":"2021","journal-title":"Front Pediatr"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.3390\/jcm11154543","article-title":"Proadrenomedullin in the management of COVID-19 critically ill patients in intensive care unit: a systematic review and meta-analysis of evidence and uncertainties in existing literature","volume":"11","author":"Montrucchio","year":"2022","journal-title":"J Clin Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jinf.2016.01.002","article-title":"Biomarkers for predicting short-term mortality in community-acquired pneumonia: a systematic review and meta-analysis","volume":"72","author":"Viasus","year":"2016","journal-title":"J Infect"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/inf.0000000000003336","article-title":"Urinary proadrenomedullin and disease severity in children with suspected community-acquired pneumonia","volume":"40","author":"Florin","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"B61","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12879-015-1095-5","article-title":"Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study","volume":"15","author":"Alcoba","year":"2015","journal-title":"BMC Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1093\/cid\/ciaa1138","article-title":"Proadrenomedullin predicts severe disease in children with suspected community-acquired pneumonia","volume":"73","author":"Florin","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"bvab045","DOI":"10.1210\/jendso\/bvab045","article-title":"Activation of vasopressin system during COVID-19 is associated with adverse clinical outcomes: an observational study","volume":"5","author":"Gregoriano","year":"2021","journal-title":"J Endocr Soc"},{"key":"B64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2362.2007.01762.x","article-title":"Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections","volume":"37","author":"M\u00fcller","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.19082\/4880","article-title":"Predictive value of copeptin as a severity marker of community-acquired pneumonia","volume":"9","author":"Mohamed","year":"2017","journal-title":"Electron Physician"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e002395","DOI":"10.1136\/bmjpo-2023-002395","article-title":"Role of soluble urokinase plasminogen activator receptor in critically ill children with hospital-acquired pneumonia: an observational study in hospital with controls","volume":"8","author":"Saleh","year":"2024","journal-title":"BMJ Paediatr Open"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2014_40","article-title":"Soluble urokinase plasminogen activator receptor: an indicator of pneumonia severity in children","volume":"835","author":"Wrotek","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/mcc.0000000000000442","article-title":"The current status of biomarkers for the diagnosis of nosocomial pneumonias","volume":"23","author":"Salluh","year":"2017","journal-title":"Curr Opin Crit Care"},{"key":"B69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/1040841x.2020.1751060","article-title":"The role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infections","volume":"46","author":"de Oliveira Matos","year":"2020","journal-title":"Crit Rev Microbiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1004057","DOI":"10.1371\/journal.pmed.1004057","article-title":"Immune and endothelial activation markers and risk stratification of childhood pneumonia in Uganda: a secondary analysis of a prospective cohort study","volume":"19","author":"McDonald","year":"2022","journal-title":"PLoS Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13613-016-0160-6","article-title":"Diagnostic and prognostic value of soluble CD14 subtype (presepsin) for sepsis and community-acquired pneumonia in ICU patients","volume":"6","author":"Klouche","year":"2016","journal-title":"Ann Intensive Care"},{"key":"B72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijid.2022.02.054","article-title":"Presepsin as a novel biomarker in predicting in-hospital mmortality in patients with COVID-19 pneumonia","volume":"118","author":"Assal","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.21037\/jtd.2019.03.74","article-title":"Impact of initial plasma presepsin level for clinical outcome in hospitalized patients with pneumonia","volume":"11","author":"Ugajin","year":"2019","journal-title":"J Thorac Dis"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1417644\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:33:48Z","timestamp":1727742828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1417644\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":73,"alternative-id":["10.3389\/fped.2024.1417644"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1417644","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"article-number":"1417644"}}